ODAC Prefers Three-Hour Taxol Infusion. Says Data Dosage Still Uncertain
In Brief: Lasker Awards; Blobel, Metcalf, Wexler, Rogers; Borch Named Center Director
ODAC Okays First “Paper NDA,” By BMS For Bieomycin
ASCO Sees Efforts Pay Off In Health Care Reform: Clinical Trials
DOD Breast Cancer Program Releases Research Solicitation
NCI Bypass Budget Seeks $3.6 Billion for Fiscal 1995
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Trump plans a 200% tariff on imported generic drugs by 2029, raising fears of cancer drug shortages
“There is a reason why generics have been exempt from all the tariffs until now,” Brookings economist warns - Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - Prediction markets now allow betting on clinical trial results, FDA decisions
It’s a high-risk bet: Insider trading, equipoise, integrity of research, public trust are at stake - Hegseth offers soldiers testosterone and FDA loosens safety warnings. Is the science there?
- Cancer hospitals brace for impact, as CMS moves to slash 340B payments by 33%









